The real culprit behind Alzheimer’s disease
April 28th, 2010 - 1:47 pm ICT by ANIWashington, April 28 (ANI): Researchers at the Mount Sinai School of Medicine have found that the real culprit behind Alzheimer’s disease is the Amyloid-Beta (Abeta) oligomers in the brain, and not the Amyloid-Beta plaques as many believed.
“The buildup of amyloid plaques was described over 100 years ago and has received the bulk of the attention in Alzheimer’s pathology. But there has been a longstanding debate over whether plaques are toxic, protective, or inert,” said lead author Sam Gandy, Professor of Neurology and Psychiatry, and Associate Director of the Alzheimer’s Disease Research Center, Mount Sinai School of Medicine.
Several research groups had previously proposed that rather than plaques, floating clumps of amyloid (called oligomers) are the key components that impede brain cell function in Alzheimer’s patients.
To study this, the Mount Sinai team developed a mouse that forms only these oligomers, and never any plaques, throughout their lives.
The researchers found that the mice that never develop plaques were just as impaired by the disease as mice with both plaques and oligomers.
Moreover, when a gene that converted oligomers into plaques was added to the mice, the mice were no more impaired than they had been before.
“These findings may enable the development of neuroimaging agents and drugs that visualize or detoxify oligomers. New neuroimaging agents that could monitor changes in Abeta oligomer presence would be a major advance,” said Dr. Gandy.
“Innovative neuroimaging agents that will allow visualization of brain oligomer accumulation, in tandem with careful clinical observations, could lead to breakthroughs in managing, slowing, stopping or even preventing Alzheimer’s.
“This is especially important in light of research reported in March showing that 70 weeks of infusion of the Abeta immunotherapeutic Bapineuzumab cleared away 25 percent of the Abeta plaque, yet no clinical benefit was evident,” Dr. Gandy added.
The study appears in the journal Annals of Neurology. (ANI)
- Mechanism behind gene linked to both Alzheimer's, diabetes identified - Sep 29, 2010
- Indications of Alzheimer's may be evident decades before first signs - Mar 29, 2011
- Turmeric-based drug being tested against Alzheimer's - Feb 15, 2012
- Key Alzheimer's risk gene causes alterations in shapes of brain protein deposits - Jul 15, 2010
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
- How Alzheimer's plaques lead to loss of nitric oxide in brain - Jan 11, 2011
- Drug reverses Alzheimer's symptoms in mice: Study - Feb 10, 2012
- Second molecule in Alzheimer's toxic duo identified - Feb 04, 2011
- Asthma drug could help fight Alzheimer's - Mar 27, 2011
- Revolutionary jab to halt Alzheimer's may be available within two years - Apr 23, 2011
- Early Alzheimer's Develops In Critical Brain Region And Then Spreads, Study Reveals - Nov 05, 2010
- How are brain cells possessed and damaged by demons of dementia - Mar 04, 2010
- Scientists reverse loss of smell in early Alzheimer's - Dec 01, 2011
- New method to cleanse brain of Alzheimer's plaques developed - Dec 10, 2010
- Asthma drug could help fight Alzheimer's disease - Mar 26, 2011
Tags: 100 years, accumulation, alzheimer, amyloid plaques, associate director, brain cell, clinical benefit, clinical observations, clumps, culprit, gandy, longstanding debate, mice, mount sinai school, mount sinai school of medicine, neurology, oligomers, pathology, research groups, school of medicine